Interv Akut Kardiol 2011; 10(5-6): 254-255
The PRODIGY study is the first randomized prospective study to compare short-term (6 months) and long-term (24 months) dual antiplatelet
therapy after coronary stent implantation. Prevention of ischaemic complications in patients is comparable in both types of treatment.
Long-term dual antiplatelet therapy results in a significantly higher rate of severe bleeding complications and this risk increases with
the duration of treatment. The facts revealed are serious and should lead to modifications of the guidelines for the treatment of patients
after coronary stent implantation.
Published: November 1, 2011 Show citation